L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
54,600
-600 (-1.09%)
Jan 19, 2026, 3:30 PM KST
123.31%
Market Cap1.36T
Revenue (ttm)79.99B
Net Income (ttm)78.00B
Shares Out24.84M
EPS (ttm)3,050.54
PE Ratio17.74
Forward PEn/a
Dividend50.00 (0.09%)
Ex-Dividend DateDec 29, 2025
Volume200,804
Average Volume431,321
Open54,200
Previous Close55,200
Day's Range53,800 - 55,600
52-Week Range18,490 - 80,000
Beta1.19
RSI36.56
Earnings DateFeb 13, 2026

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 141
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.